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Abstract
We determined the complete nucleotide sequence of the New World simian foamy virus (FV) from spider monkey (SFVspm). Starting from a
conserved region in the integrase (IN) domain of the pol gene we cloned fragments of the genome up to the 5′ end of the long terminal repeat
(LTR) into plasmid vectors and elucidated their nucleotide sequence. The 3′ end of the genome was determined by direct nucleotide sequencing of
PCR products. Each nucleotide of the genome was determined at least two times from both strands. All protein motifs described to be conserved
among primate FVs were found in SFVspm. At both the nucleotide and protein levels SFVspm is the most divergent primate FV described to date,
reflecting the long-term phylogenetic separation between Old World and New World primate host species (Catarrhini and Platyrrhini,
respectively). The molecular probes developed for SFVspm will allow the investigation of trans-species transmissions of this New World foamy
virus to humans by serological assays.
© 2007 Elsevier Inc. All rights reserved.Keywords: Foamy viruses; Retrovirus; New World monkeys; Primate evolution; Spider monkey virusIntroduction
Studies into the prevalence and molecular biology of FVs
have attracted increased scientific interest in recent years.
First, the risk of accidentally acquiring a primate FV infection
through contact to non-human primates appears to be much
higher than for any other retrovirus (Heneine et al., 2003;
Heneine et al., 1998; Switzer et al., 2004). Although there is,
so far, no indication of a pathogenic potential of these viruses
and for human-to-human transmissions (Heneine et al., 2003),
the potential of a new zoonotic infection has generated con-
siderable concern (Switzer et al., 2004). New World monkeys
are often kept as pets in Northern America and the risk to
attract a FV infection through contact with these has been
pointed out (Brooks et al., 2002). In addition, the hunting of
New World primates poses a risk of zoonotically acquir-
ing simian virus infections (Anonymous, 2007; Wolfe et al.,
2005).⁎ Corresponding author. Fax: +49 931 201 49553.
E-mail address: virologie@mail.uni-wuerzburg.de (A. Rethwilm).
0042-6822/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2007.07.018Second, Spumaretrovirinae have adopted a replication
pathway distinct from Orthoretrovirinae (for reviews see
Linial, 2007 and Rethwilm, 2005). Although still currently
under investigation, it appears that the FV replication strategy
represents a bridge between those of the orthoretroviruses and
hepadnaviruses (Rethwilm, 2003).
Third, in the field of gene therapy FV vectors become
increasingly attractive due to certain advantages they appear to
have over orthoretrovirus vectors (for a recent review, see
Rethwilm, 2007). However, much has still to be learned on
these viruses before it comes to the application of the vectors to
humans.
Finally, FVs are the genetically most stable viruses known to
replicate through an RNA intermediate and can be taken as
surrogate phylogenetic markers for the evolution of their hosts
(Schweizer and Neumann-Haefelin, 1995; Switzer et al., 2005;
Verschoor et al., 2004). However, this property of virus–host
co-divergence was only demonstrated for the Old World non-
human primates, with no available data from New World
primates (Switzer et al., 2005). For these reasons we determined
the complete nucleotide sequence of SFVspm (previously
known as SFV-8), the first from a New World primate.
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Strategy for cloning SFVspm
The strategy of cloning the FV isolate from the spider
monkey (Ateles ssp.) was analogous to that used to clone other
FV genomes (Bodem et al., 1996; Herchenröder et al., 1994;
Holzschu et al., 1998; Tobaly-Tapiero et al., 2000). The virus
was obtained from the American Type Culture Collection
(ATCC) and grown on human MRC-5 fibroblasts until the
pathognomonic cytopathic effect (CPE) became visible.
Taking advantage of the highly conserved IN domain an
approximately 410 bp fragment was initially and specifically
amplified from the DNA of infected cultures with primers
developed by Schweizer and Neumann-Haefelin (1995) (data
not shown). After determination of the amplimer nucleotide
sequence an isolate specific reverse primer was designed and a
forward primer located in the protease (PR) region of the pol
gene that we found to be relatively conserved among primate
FV sequences. With these two primers a 2.50 kb fragment
spanning most of the pol gene was then obtained. Next, we
amplified a 3.50 kb fragment spanning the complete gag gene
with a PR-specific reverse primer and a forward primer
derived from the primer binding site (PBS) that is conserved
among FVs (Maurer et al., 1988). To obtain a 5′ LTR
fragment we digested the cellular DNA from SFVspm-infected
cells with HindIII that cuts in gag approximately 350 bp
downstream of the PBS. After re-ligation, inverse amplifica-
tion was carried out with a forward and a reverse primer,
which both are located in gag 5′ to the HindIII site. An ap-
proximately 1.55 kb amplimer was generated and cloned. The
sequence analysis revealed that we had isolated the complete
5′ LTR.
However, unintegrated DNA that circularized from the
HindIII restriction site in gag to the blunted 5′ end of the viral
DNA was the source of our amplification product. We regard
the illegitimate ligation of a blunted LTR DNA end with a
sticky one to occur relatively frequently with viral DNA from
FV-infected cells since the 3′ LTR of the prototype FV (PFV)
isolate was obtained similarly after BamHI digestion
(Rethwilm et al., 1987). The reason may be the large amount
of non-integrated viral DNA in FV-infected cells generated by
“late” reverse transcription (Moebes et al., 1997; Roy et al.,
2003; Yu et al., 1999).Fig. 1. Genetic map of the SFVspm provirus with conserved motifs. The primer bin
signal (CTRS), glycine–arginine-rich boxes (GR-boxes), proteolytic cleavage sites
residues important for enzymatic function (DTG, YVDD, DSHN, and HHCC, DD3
leader peptide (LP), surface (SU), and transmembrane (TM) proteins of Env, the inte
are indicated.After cloning the 5′ part of the SFVspm genome from the start
of the 5′ LTR to the integrase and then determining its nucleotide
sequence, we generated the 3′ part of the viral genome in a
similar way. A forward primer in the IN domain was designed
and a reverse primer in the 3′ LTR. The PCR reaction generated
an approximately 5.98 kb fragment that we were unable to clone
into a plasmid vector. Therefore we decided to determine the
DNA sequence the PCR fragment directly. A genetic map of
SFVspm and some conserved motifs is shown in Fig. 1.
Nucleotide sequence of SFVspm
Using among all FVs conserved 18 nt PBS for the lysine1,2
tRNA (Maurer et al., 1988), the overall length of the LTR was
determined to be 1252 bp. Based on nucleotide motifs
conserved among retroviruses the approximate length of U3,
R, and U5 were deduced to be 930, 165, and 158 nt,
respectively. While the length of R and U5 length appear to
be in the range of all other FV genomes, the U3 is considerably
shorter than the U3s from primate FVs and resembles in length
more the non-primate FVs (Table 1).
In addition to the start of transcription in the LTR, FVs bear
an internal promoter (IP), which is located at the end of the env
gene sequence (Löchelt et al., 1993). Motifs of eukaryotic
promoters, such as a TATA box, that most likely belong to the IP
(Fig. 1) were identified upstream of the accessory open reading
frames (ORFs).
The 3′ poly purine tract (PPT) marks the border of the 3′
LTR (Fig. 1). Similar to lentiviruses FVs possess an additional
PPT located in the center of the genome (cPPT), which poten-
tially can serve as an internal start of second strand transcription
(Tobaly-Tapiero et al., 1991). However, the exact function is
so far ill defined. A perfect match to the downstream 9 nt of
the 3′ PPT was found at the expected central position of the
SFVspm genome.
As all retroviruses FVs are diploid (Erlwein et al., 1997). The
dimerization sequence at the 5′ end of the PFV genome contains
a perfectly conserved 10 bp palindrome (Cain et al., 2001;
Erlwein et al., 1997), the integrity of which has been shown to
be critical for (pre-) genome dimerization and viral replication
(Cain et al., 2001). Sequence determination of ten individual
molecular clones revealed an 8 bp palindrome in SFVspm in a
similar position that likely serves a function in dimerizing the
SFVspm (pre-) genome (Fig. 1).ding site (PBS), dimer linkage site (DLS), cytoplasmic targeting and retention
(CS), probable late budding and capsid assembly domains (PSAP and YXXL),
5E), the location of the central and 3′ poly purine tracts (cPPT and 3′PPT), the
rnal promoter (IP), and the Tas protein-located nuclear localization signal (NLS)
Table 1
Overview of FV LTRs and ORFs a
Virus/region SFVspm PFV SFVcpz SFVora SFVmac SFVagm FFV BFV EFV
LTR 1251 1767 1760 1621 1621 1710 1353 1305 1449
U3 930 1423 1426 1286 1321 1333 1070 981 1124
R 164 190 180 177 168 215 134 173 171
U5 157 154 154 158 132 162 149 151 154
Gag 623 648 653 624 647 643 574 544 559
Pol 1148 1143 1146 1145 1149 1143 1156 1220 1153
Env 986 988 988 989 989 982 982 990 986
LP 129 126 126 126 126 126 127 123 122
SU 442 445 445 446 447 441 434 449 441
TM 415 417 417 417 416 415 419 418 423
Tas 324 300 300 278 308 298 209 249 249
Bet 374 482 490 464 487 469 387 435 440
a The length of the LTR regions is in nucleotides, and those of ORFs in amino acids. The length of the LP proteins was deduced from the primary sequences except
for PFV and FFV where they have been determined experimentally (Duda et al., 2004, Geiselhart et al., 2004).
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While the majority of nucleic acid motifs and definitive
splice sites of SFVspm need to be determined by functional
characterization and transcript mapping studies, a variety of
protein motifs could be unambiguously assigned to the deduced
amino acid sequences based on sequence similarity to other
FVs.
The Gag ORF has a length of 623 residues is more similar to
the other primate than to the non-primate FVs (Fig. 1 and Table
1). The FV Gag protein is not cleaved into mature matrix,
capsid, and nucleocapsid subunits (Linial and Eastman, 2003).
Only a small peptide is cleaved from the Gag C-terminus. The
cleavage site has been experimentally determined for PFV to be
RAVN/TVTQ, which generates a 27 amino acid C-terminal
peptide of approximately 3 kDa molecular weight (Flügel and
Pfrepper, 2003; Zemba et al., 1998). Taking similar residues the
cleavage site in SFVspm would be at aa 586 of the Gag protein
and the resultant C-terminal peptide of 37 aa length and of
approximately 3.7 kDa MW (Fig. 1). Three boxes rich in
glycines and arginines (GR-boxes) have been identified and
provisionally been characterized in the PFV isolate (Schlie-
phake and Rethwilm, 1994; Yu et al., 1996). Three similar
sequence motifs were found in SFVspm. The first is located
between aa positions 454 to 483. This box I most likely harbors
the nucleic acid-binding motif of SFVspm (Yu et al., 1996). Box
II appears to be located between aa positions 516 to 534.
Whether this element harbors a nuclear localization signal
(NLS), as shown for PFV (Schliephake and Rethwilm, 1994),
remains to be determined. Box III would run aa 556 to 572. Any
function to the box III element has not been assigned yet.
Furthermore, the presence of the GR-boxes appears to be a
particular feature of primate FVs since FVs of lower animals do
not bear such elements as far as this has been characterized
(Bodem et al., 1998).
FV requires the presence of a late domain (L-domain) (Patton
et al., 2005; Stange et al., 2005) for efficient budding. The L-
domain sequence (PSAP) facilitates viral particle egress
through interaction with the cellular export machinery (Freed,
2004; Stange et al., 2005). While the PSAP motif is highlyconserved in primate FV Gag sequences its position within Gag
is variable (Stange et al., 2005). Three perfectly conserved
PSAP motifs were found in the SFVspm sequence, located at aa
223 to 226, aa 244 to 247, and aa 597 to 600 of the Gag ORF in
Fig. 1. It is likely that at least one of these elements serves a
similar function as the PSAP motif described for PFV (Patton et
al., 2005; Stange et al., 2005). Interestingly, the downstream
element was identified to be located in the C-terminal peptide
that is cleaved from the main body of the Gag protein during
maturation. It is unclear whether the location of this element
allows for any L-domain function.
Two YXXLmotifs were found at aa positions 107 and 538 in
SFVspm Gag (Fig. 1). An YXXL motif has recently been
shown for PFV to function unlike an L-domain and to be instead
essential for correct particle assembly (Mannigel et al., 2007).
The conserved R residue in Gag that is implicated in particle
formation in the cytoplasma (Eastman and Linial, 2001) was
located at SFVspm aa position 48, and a potential cytoplasmic
targeting and retention signal (CTRS) was identified in SFVspm
Gag downstream of aa position 36 (Cartellieri et al., 2005).
The Pol ORF has a length of 1148 aa (Fig. 1 and Table 1). As
in all primate FVs the active center of the PR is of the sequence
DT/SG. In FVs PR and the reverse transcriptase (RT) are not
cleaved efficiently, if at all (Flügel and Pfrepper, 2003). The
only viral PR-mediated cleavage that is known to occur in FV
Pol proteins is the one between PR-RT and IN (Flügel and
Pfrepper, 2003). Based on sequence similarity to other FV IN
cleavage sites it is likely that the motif YSVN/TINK is used to
separate the two Pol moieties in SFVspm (Fig. 1). This would
result in 747 aa PR-RTand 401 aa IN proteins (Table 1). The RT
active center (YVDD) is located at aa 308 to 311 in Pol and the
catalytic important residues of the RNaseH domain (Boyer et
al., 2004) at aa 666 to 732. The IN zinc-binding motif was
identified at H809-H813-C843-C846 and the IN active center
(DD35E) at D875-D932 and E968 (Fig. 1).
The Env ORF has 986 aa (Fig. 1 and Table 1). While the
mature orthoretroviral Env is made up of two subunits, the
surface (SU) and the transmembrane (TM) proteins (Swanstrom
and Wills, 1997), spumaretroviral Envs are three subunit
proteins, made up of a long leader peptide (LP), SU and TM
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al., 2001). Although this has only been characterized in detail for
the PFVand FFV isolates, it is likely that this topological feature
applies to all FVs. The LP is a type II transmembrane protein
and has the function to make specific contact to cognate viral
capsids with its long cytoplasmic N-terminus (Geiselhart et al.,
2003; Lindemann et al., 2001; Wilk et al., 2001). The cleavages
between LP and SU and between SU and TM are mediated by
cellular furin-like proteases (Duda et al., 2004; Geiselhart et al.,
2004). An LP/SU-cleavage likely occurs C-terminal of R129 and
the SU/TM-cleavage probably C-terminal of R571 (Fig. 1). Such
cleavages would result in particle-associated 129 aa LP, 442 aa
SU, and 415 aa TM proteins (Table 1).
Furthermore, some specific domains could be assigned to the
individual Env proteins. The LP consists of N-terminal
cytoplasmic and C-terminal extra-cellular regions, which are
separated by a hydrophobic membrane-spanning region (Lin-
demann et al., 2001). This hinge region was located from aa 59
to 95 by hydrophobicity analysis. Following the predictions of
Wang and Mulligan (68) the TM-located fusion peptide (FP)
extends from residues 572 to 589, and the membrane-spanning
domain (MSD) from 949 to 973. All FV Env precursors possess
ER retention signals at the C-terminus of TM with the lysine in
position −3 being the most important (Goepfert et al., 1995).
This element was found in the expected position and consists of
the residues KRK984.
The Tas ORF has a length of 314 residues. FV transactivators
are DNA-binding proteins that comprise an acidic activation
domain at the C-terminus and a poorly characterized virus-
specific DNA-interacting domain at the N-terminus which are
implicated in binding IP and U3 sequences. Both domains are
separated by a basic NLS (He et al., 1993; Rethwilm, 1995).
These motifs could be assigned to the deduced protein sequence
of the SFVspm Tas protein. The DNA-binding domain is poorlyFig. 2. Unrooted maximum likelihood (Tree-Puzzle) tree of pol amino acid sequences
depict quartet puzzling support values. All branch lengths are scaled to the numbercharacterized for any FV and extends to aa 242, the NLS
probably from aa 243 to aa 247, and the acidic activation domain
is likely located downstream of the NLS with the core domain
from aa 260 to aa 312 (He et al., 1993; Rethwilm, 1995).
Bet is a highly expressed and often immunodominant FV
protein, which is generated by a multi-spliced mRNA contain-
ing coding exons from the first and the second accessory ORFs.
The function of Bet has generated considerable controversy
(Delebecque et al., 2006; Löchelt et al., 2005; Russell et al.,
2005). It is possible that FV Bet proteins counteract host
APOBEC cytidine deaminases by making use of an alternative
strategy to the human immunodeficiency virus (HIV) Vif
protein (Cullen, 2006). The proposed SFVspm Bet protein has a
length of 375 residues (Fig. 1 and Table 1). Since functional
domains have not yet been described for any of the FV Bet
proteins, we could not assign those to SFVspm.
Evolutionary relationships of SFVspm
To determine the evolutionary relationship between SFVspm
and the other simian foamy viruses we undertook a phylogenetic
analysis of the translated pol amino acid sequences of six
primate FVs (the amino acid sequences of the non-primate FVs
were deemed too divergent for meaningful phylogenetic
analysis). The maximum likelihood tree (Fig. 2) clearly reveals
that SFVspm is the most divergent member of the simian foamy
viruses identified to date, consistent with its infection of New
World monkey host species (Platyrrhini), whereas the remaining
primate FVs infect Old World monkeys and apes (Catarrhini).
This inference is supported by the identification in SPVspm
of specific protein motifs, mainly in Gag, that are exclusive to
FVs from primates. The L-domain PSAP is highly conserved
among the primate viruses and is absent from the FVs of lower
mammals. FFV, EFV, and BFV possess other sequences, whichfrom six primate FVs including SFVspm. Numbers next to the specific branches
of amino acid substitutions per site.
Table 2
Percentages of amino acid similarities between SFVspm and different FVs
ORF/virus PFV SFVcpz SFVora SFVmac SFVagm FFV BFV EFV
Gag 49.2 49.8 49.3 47.7 47.8 55.9 44.9 45.4
Pol 78.8 79.8 79.1 79.9 78.7 73.8 75.3 76.2
Env (total) 71.6 71.2 68.9 69.0 67.7 62.5 62.5 63.0
LP 64.1 65.0 62.8 62.0 59.7 56.1 61.9 56.1
SU 71.1 69.8 66.7 68.8 67.0 60.5 55.1 58.0
TM 75.7 76.1 74.5 72.5 72.7 71.7 73.9 74.8
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Such elements, of the sequence YXXL, can also be found in all
sequenced primate FV Gags (Patton et al., 2005; Stange et al.,
2005). However, it has been shown for PFV recently that they
are implicated in correct Gag assembly instead of promoting the
budding process (Mannigel et al., 2007).
The GR-boxes at the C-terminus of Gag constitute the other
Gag-related motifs that appear to be confined to the primate
FVs. Little is known about the function of the three GR-boxes,
which were first identified in PFV (Schliephake and Rethwilm,
1994). The nucleic acid-binding element in box I was found to
be required for virus replication, while deletion of the NLS in
box II appeared to have only modest effects on viral titers (Yu
et al., 1996).
Discussion
Previous studies have shown that FV genomes from non-
human primates can serve as surrogate markers for the phylo-
genetic relationships of their hosts (Schweizer and Neumann-
Haefelin, 1995; Switzer et al., 2005). Platyrrhini (New World
primates) diverged from a common ancestor with Catarrhini
(Old World primates) between 43 and 35 million years ago
(MYA) (Schrago and Russo, 2003; Steiper and Young, 2006).
This deep divergence is also reflected in the divergent
relationship of the spider monkey SFVspm from the other
primate FVs (Fig. 2 and Table 2). Because of this host–virus co-
divergence FV genomes are estimated to evolve at an extremely
low rate of 1.7×10−8 per site and year, the lowest rate recorded
for viruses having an RNA genome phase and approximates the
pace of DNA virus evolution (Switzer et al., 2005) and which
may be important when the application of FV vectors in gene
therapy is considered.
The low in vivo replication rate of FVs is the most likely
reason for their genomic stability (Murray and Linial, 2006;
Switzer et al., 2005). This view is strengthened by the recent
analysis of the fidelity of the PFV RT enzyme that was found to
be in the range of HIV RT by in vitro assays (Boyer et al., 2007).
When considering particular features of the FV replication
strategy and reflecting the genome stability, we note that in
functional terms FVs have a DNA genome and replicate
through an RNA intermediate, while orthoretroviruses can be
regarded as RNA viruses replicating through a DNA inter-
mediate (Rethwilm, 2003). Furthermore, there is no evidence
that the process of “late” reverse transcription involves a proof
reading activity and the steps of generating viral DNA are likely
to be similar between spuma- and orthoretroviruses (Rethwilm,2003). However, the actual circumstances of reverse transcrip-
tion are probably different between these two retroviral
subfamilies (reviewed by Rethwilm, 2003 and 2005). Indeed,
it may be that the fidelity of FV RT in its natural context is much
higher than estimated by in vitro assays.
Primate FV genomes were estimated to be at least 30 million
years old (Switzer et al., 2005). This calculation was based on
Old World FV sequences. With the SFVspm sequence
determined here we can extend this age to the separation
between Catarrhini and Platyrrhini. According to our findings
FVs acquired motifs in Gag, such as the L-domain PSAP and
the GR-boxes, during co-divergence with their primate hosts
and separating from the non-primate viruses. Since the ancestor
of FVs is not known and the sequence of the prosimian FV from
the Galago (SFVgal) remains to be elucidated, we cannot yet
exclude the alternative possibility of non-primate FVs deleting
specific Gag elements from a virus at the root of a hypothetical
FV tree.
Materials and methods
Virus cultivation
Primary MRC-5 human fibroblasts were cultivated in
modified Eagles medium that was supplemented with 10%
fetal calf serum and antibiotics. The SFVspm isolated studied
here which was originally collected by John Hooks et al. from a
spider monkey brain in 1973 (Hooks et al., 1973) was obtained
from ATCC (lot # 218093) and added to the cells. Virus and
cells were cocultured and cells were split 1:5 after reaching
confluency. After 3 days a CPE typical for FVs became visible.
Amplification and molecular cloning of SFVspm nucleic acids
DNA was extracted from SFVspm-infected cells and from
uninfected MRC-5 cells on day five of culture using the
DNeasy kit (Qiagen). The amplification of SFVspm was
usually performed with 100–300 ng of DNA from infected
cells, 15 pmol of both primers, 2.75 mM MgCl2, and the
Expand Long Template PCR System (Roche) for 35 cycles
with 94 °C for 10 s, primer annealing at 50 °C for 30 s, and
elongation at 72 °C for 2 min. From the 10th cycle onwards
every polymerization step was elongated for 20 s. Amplimers
were run in agarose gels, stained with crystal violet, the desired
fragments were extracted with the Qiaquick Gel extraction kit
(Qiagen), and inserted into the pCRII-Topo or pCR-XL-Topo
cloning vectors (Invitrogen). Following screening of small-
scale DNA preparations for the expected insert size by EcoRI
digestion the viral inserts were DNA sequenced. The sequences
of the primers used for amplification are available as
supplementary information under http://viminfo.virologie.
uni-wuerzburg.de/onlinematerial/Thuemer/pdf.
Sequence determination
Viral DNA sequences of the cloned virus were obtained
using initially M13 forward or reverse primers on an ABI
196 L. Thümer et al. / Virology 369 (2007) 191–197PRISM 3100 Genetic Analyzer automated sequencing device
(Applied Biosystems). The PCR amplimers of the 3′ region of
the genome were directly sequenced using initially the
amplification primers. Primer walking was then used to obtain
the new sequence. All nucleotides of the SFVspm genome were
determined at least two times for both strands. The sequences of
the primers used for DNA sequencing and the complete
SFVspm DNA sequence are available as supplementary
information under the web address given above. The nucleotide
sequence of SFVspm has also been deposited to GenBank under
the accession number EU010385.
Evolutionary analysis
Sequence comparisons to other FVs were made using
ClustalW and published sequences of PFV (prototype FV;
accession number Y07725); SFVcpz (Chimpanzee FV;
U04327); SFVora (Orang Utan FV; AJ544579); SFVmac
(Macaque FV; X54482); SFVagm (African Green Monkey
FV; M74895). The sequences from other mammalian FVs were
considered too divergent for meaningful phylogenetic analysis.
A phylogenetic tree of these sequences was inferred from the
translated amino acid sequences of the most highly conserved
pol gene (alignment of 1152 residues) using the maximum
likelihood (ML) method available in the Tree-Puzzle package
(Strimmer and von Haeseler, 1996). The tree was inferred using
the WAG+G model of amino acid substitution with the shape
value (0.5) of the G-distribution estimated from the empirical
data. Quartet puzzling was used to assess the support for speci-
fic nodes on the tree.
Finally, protein hybrophobicity was analyzed with the
pepwindow software. The protein similarities among the viruses
are shown in Table 2 and were calculated with the EMBOSS
software at the European Molecular Biology Open Software
Suite (Rice et al., 2000). Splice sites were predicted using
NNSPLICE (version 0.9) (Reese et al., 1997).
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